These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12923636)

  • 21. Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer.
    John T; Yanagawa N; Kohler D; Craddock KJ; Bandarchi-Chamkhaleh B; Pintilie M; Sykes J; To C; Li M; Panchal D; Chen W; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Jul; 7(7):1101-8. PubMed ID: 22617243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer.
    John T; Kohler D; Pintilie M; Yanagawa N; Pham NA; Li M; Panchal D; Hui F; Meng F; Shepherd FA; Tsao MS
    Clin Cancer Res; 2011 Jan; 17(1):134-41. PubMed ID: 21081655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
    Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G
    Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
    J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM; Kennedy C; McLean J; McCaughan BC
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
    Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
    J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer.
    Gebbia V; Bellavia M; Banna GL; Russo P; Ferraù F; Tralongo P; Borsellino N
    Clin Lung Cancer; 2013 Jul; 14(4):390-8. PubMed ID: 23313173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
    Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
    PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
    Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer in Spanish women: The WORLD07 project.
    Garrido P; Viñolas N; Isla D; Provencio M; Majem M; Artal A; Carcereny E; Garcia Campelo R; Lianes P; De La Peñas R; Felip E
    Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12941. PubMed ID: 30277293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.